Cargando…

COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of coronavirus disease 2019 (COVID-19). It is known as a respiratory virus, but SARS-CoV-2 appears equally, or even more, infectious for the olfactory epithelium (OE) than for the respiratory epithelium in the nas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Fengyi, Wang, De Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625547/ https://www.ncbi.nlm.nih.gov/pubmed/34835030 http://dx.doi.org/10.3390/v13112225

Ejemplares similares

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
por: Bauer, Lisa, et al.
Publicado: (2023)

Neurotropism of SARS-CoV 2: Mechanisms and manifestations
por: Conde Cardona, Giancarlos, et al.
Publicado: (2020)

Emerging neurotropic features of SARS-CoV-2
por: Zhan, Wen-Rong, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms
por: Zhou, Zhiqiang, et al.
Publicado: (2020)

Presence of SARS‐CoV‐2 in plural effusion with COVID‐19 patients
por: Ataee, Zahra, et al.
Publicado: (2021)

Molecular and Pathological Investigations of Selected Viral Neuropathogens in Rabies-Negative Brains of Cats and Dogs Revealed Neurotropism of Carnivore Protoparvovirus-1
por: Wardhani, Sabrina Wahyu, et al.
Publicado: (2021)

Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection
por: Lao, Wilson P., et al.
Publicado: (2020)

Can’t smell the virus: SARS-CoV-2, chromatin organization, and anosmia
por: Sorek, Matan, et al.
Publicado: (2022)

Association of anosmia and neutralizing antibody production in adolescents with SARS-CoV-2
por: Gitman, Lyuba, et al.
Publicado: (2023)

Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids
por: Ramani, Anand, et al.
Publicado: (2021)

Screening Pesticides for Neuropathogenicity
por: Doherty, John D.
Publicado: (2006)

Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
por: Lechner, Matt, et al.
Publicado: (2020)

Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia
por: Bagasra, Omar, et al.
Publicado: (2021)

Viral Shedding and Persistence of Anosmia and Ageusia in an Asymptomatic SARS-CoV-2 Infection
por: Kintrilis, Nikolaos
Publicado: (2023)

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses
por: Hu, Jingman, et al.
Publicado: (2020)

The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury
por: Vavougios, George D.
Publicado: (2020)

ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
por: Wang, Cheng, et al.
Publicado: (2021)

New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection
por: Patel, A., et al.
Publicado: (2020)

Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium
por: Reyna, Rachel A., et al.
Publicado: (2022)

Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
por: de Melo, Guilherme Dias, et al.
Publicado: (2023)

Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2
por: Karimian, Ali, et al.
Publicado: (2022)

Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia in pediatric cases
por: Hatipoglu, Nevin, et al.
Publicado: (2020)

Sudden onset anosmia and dysgeusia in two patients: An early sign of SARS-CoV-2 infection
por: Alamri, Ahmad, et al.
Publicado: (2020)

Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report
por: Galougahi, Mahboobeh Karimi, et al.
Publicado: (2020)

Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
por: Veleri, Shobi
Publicado: (2021)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

NEUROPATHOGENICITY OF GROUP A COXSACKIE VIRUSES
por: Dalldorf, Gilbert
Publicado: (1957)

Emerging evidence of neuronal cells-targeting SARS-CoV-2 causing anosmia associated with COVID-19
por: Baig, Abdul Mannan
Publicado: (2022)

Risk Factors for Persistent Anosmia and Dysgeusia in Children with SARS-CoV-2 Infection: A Retrospective Study
por: Mariani, Francesco, et al.
Publicado: (2023)

Vaccination against SARS-CoV-2 Does Not Protect against the Development of Anosmia in a Hamster Model
por: Reyna, Rachel A., et al.
Publicado: (2023)

Author Correction: Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
por: de Melo, Guilherme Dias, et al.
Publicado: (2023)

Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients
por: Yachou, Yassine, et al.
Publicado: (2020)

Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology
por: Pallanti, Stefano
Publicado: (2020)

Measles Fusion Machinery Is Dysregulated in Neuropathogenic Variants
por: Jurgens, Eric M., et al.
Publicado: (2015)

Microglia and astrocyte responses to neuropathogenic protozoan parasites
por: Nasuhidehnavi, Azadeh, et al.
Publicado: (2021)

Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19
por: Messlinger, Karl, et al.
Publicado: (2021)

Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
por: Jungbauer, Frederic, et al.
Publicado: (2022)

SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism
por: Sepehrinezhad, Ali, et al.
Publicado: (2021)

Central nervous system manifestations of monogenic autoinflammatory disorders and the neurotropic features of SARS-CoV-2: Drawing the parallels
por: Renson, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_10n7na01f3vvkcgli4ij9enf98